ArticleOncology reports2022

Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma.

Agnese Di Rocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.